GlobalData on MSN26d
GSK pumps up to $800m for US manufacturing site upgradeThe former facility will manufacture products based on Multiple Antigen Presenting System (MAPS) technology ... system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback